mt027
Cell therapyexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 15, 2024 (NCT06726564)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CD276 antigenImmunity, passive
CD276 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06912152 | Phase 1 | May 12, 2025 | Zhejiang University |
| NCT06737146 | Phase 1 | Jan 1, 2025 | Government of China |
| NCT06742593 | Phase 1 | Jan 1, 2025 | Chinese Academy of Medical Sciences, Government of China |
| NCT06726564 | Phase 1 | May 15, 2024 | Chinese Academy of Medical Sciences, Government of China |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 1 | 2024 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1